The justice system just sold you a sedative, and you’re swallowing it whole.
Jasveen Sangha, the so-called "Ketamine Queen," was recently sentenced to 15 years for her role in the death of Matthew Perry. The headlines are screaming about accountability. The public is nodding in somber agreement, satisfied that the "villain" is behind bars.
It’s a lie.
This sentence isn't justice; it’s a distraction. By pinning the tragic end of a beloved icon on a high-profile dealer, the courts are performing a classic sleight of hand. They want you to look at the "monster" in the mugshot so you don’t look at the catastrophic failure of the medical establishment, the absurdity of current scheduling laws, and the reality of how high-functioning addicts actually navigate the world.
The Scapegoat Protocol
Let’s be clear: Sangha is no saint. She was a merchant of high-end risk. But treating her like the primary catalyst for Perry’s death ignores the three years of systemic failure that preceded that final dose.
The media loves a "Queen." It gives a face to a faceless problem. By branding her with a comic-book moniker and locking her up for over a decade, the state creates the illusion of a "crackdown."
Ask yourself: If Sangha didn't exist, would Matthew Perry still be alive?
The data says no. When you remove a high-level distributor without addressing the underlying demand or the medical gatekeeping that drives users to the black market, you create a vacuum. That vacuum is always filled by someone less professional, less "reputable," and more dangerous. We’ve seen this play out with every substance from alcohol during Prohibition to the fentanyl crisis of the 2020s.
The Medical Gatekeeping Trap
Matthew Perry wasn't looking for a high in a gutter. He was looking for relief.
Ketamine is currently the "it" drug of the psychiatric world. It is hailed as a miracle for treatment-resistant depression. Yet, the barrier to entry for legal, supervised administration is astronomically high—not just in cost, but in bureaucratic hurdles.
When a patient with the resources of a Hollywood star cannot find sufficient relief within the "legal" framework, they will use those same resources to build a parallel one. The competitor articles focus on the "greed" of the doctors and dealers involved. That’s the lazy take.
The real story is the failure of the clinical feedback loop.
Doctors were involved in this supply chain. Why? Because the demand for this specific intervention is so decoupled from the legal supply that even licensed professionals feel "justified" in side-stepping the rules to meet it. When you criminalize the supply of a substance that people perceive as medicine, you don't stop the trade. You just remove the safety rails.
The Myth of the Vulnerable Victim
We need to stop infantalizing Matthew Perry.
He was a man who spent decades navigating the darkest corners of addiction. He wrote the book on it—literally. To suggest he was a "victim" of a predatory dealer ignores the agency of the addict.
In the recovery world, we talk about "people, places, and things." Perry knew the risks. He sought out the supply. By framing the dealer as the sole aggressor, we reinforce a dangerous narrative that addiction is something that happens to people from the outside, rather than a chronic internal struggle.
If we keep blaming the "Queens" and the "Kings," we never have to talk about why the court-mandated rehabs and the $50,000-a-month centers keep failing the people they are meant to save.
Why 15 Years Changes Nothing
Let’s look at the math of the drug trade.
The "Ketamine Queen" is off the board. Does the price of ketamine on the streets of North Hollywood go up? No. Does the purity decrease? Likely the opposite, as new players compete for her former clientele.
The 15-year sentence is a theatrical performance.
- Deterrence? Non-existent. The margins in high-end illicit drug sales are so high that the risk of a prison sentence is simply a "cost of doing business."
- Rehabilitation? The American prison system is a finishing school for crime.
- Restitution? It doesn't bring back a cultural icon.
The "lazy consensus" says this is a win for the DEA. In reality, it’s a PR victory that covers up the fact that they are losing the actual war. They are playing Whac-A-Mole while the garden is on fire.
The Counter-Intuitive Reality of Harm Reduction
If we actually cared about saving lives like Matthew Perry’s, we wouldn't be celebrating a prison sentence. We would be demanding a radical overhaul of how we handle substances that bridge the gap between "recreational" and "therapeutic."
Imagine a scenario where ketamine was available through a regulated, decriminalized framework that prioritized testing and supervised use over prohibition.
In that world:
- The "Ketamine Queen" has no market.
- The "rogue doctors" are monitored by peer-review boards, not undercover agents.
- The user isn't hiding their dosage from their primary care physician out of fear of being "cut off."
The current system forced Perry into the shadows. The shadows are where people die. Jasveen Sangha didn't kill Matthew Perry; the illegality of his needs did.
Stop Clapping for the Verdict
Every time a celebrity dies and a dealer gets a decade-plus in the federal pen, we tell ourselves the world is safer.
It isn't.
We are just more comfortable. We’ve found someone to hate, which is much easier than looking at the mirror of our failed drug policies. We are punishing a woman for being a symptom of a disease we refuse to treat.
The 15-year sentence is a bandage on a gunshot wound. It looks clean for a minute, but underneath, the patient is still bleeding out.
If you think this verdict is a "victory," you aren't paying attention. You’re just enjoying the show.
The Queen is dead. Long live the next dealer who is already taking her calls.
